Drug Profile
Lidocaine intravesicular - TARIS Biomedical
Alternative Names: LiRIS®Latest Information Update: 20 Jan 2022
Price :
$50
*
At a glance
- Originator TARIS Biomedical
- Class Acetanilides; Class Ib antiarrhythmics; Local anaesthetics; Non-opioid analgesics; Small molecules
- Mechanism of Action Sodium channel antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Interstitial cystitis
Most Recent Events
- 08 May 2020 Allergan has been acquired and merged into AbbVie
- 07 Aug 2019 No development reported - Phase-II for Interstitial cystitis in Canada, USA (Intravesicular)
- 20 Nov 2017 Allergan completes a phase II trial in Interstitial cystitis in USA and Canada (NCT02395042)